Beijing Hotgen Biotech Co., Ltd. Operating Cash Flow for the year ending December 31, 2024: USD -5.09 M

Beijing Hotgen Biotech Co., Ltd. Operating Cash Flow is USD -5.09 M for the year ending December 31, 2024, a -30.44% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Beijing Hotgen Biotech Co., Ltd. Operating Cash Flow for the year ending December 31, 2023 was USD -7.32 M, a -105.16% change year over year.
  • Beijing Hotgen Biotech Co., Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 141.83 M, a -65.92% change year over year.
  • Beijing Hotgen Biotech Co., Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 416.19 M, a 1,550.21% change year over year.
  • Beijing Hotgen Biotech Co., Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 25.22 M, a 806.60% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities